NO LyMIT: Lymphoma Microenvironment & Immune Therapies
US Focus Meeting 2026
📍 New Orleans, LA
🗓️ October 23 - 24, 2026
Last Year's Highlights
Dear Colleagues and Friends,
We are delighted to extend our warmest invitation to the NO LyMIT: Lymphoma Microenvironment & Immune Therapies Focus Meeting 2026, to be held at on October 23 - 24, 2026.
Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing NO LyMIT: Lymphoma Microenvironment & Immune Therapies research and patient treatment.
This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.
Chairs of NO LyMIT: Lymphoma Microenvironment & Immune Therapies US Focus Meeting 2026:
Christopher Flowers, MD
MD Anderson Cancer Center, Houston, TX
Michael R. Green, PhD
MD Anderson Cancer Center, Houston, TX
Supporters to be announced...
Interested in supporting this meeting? Get in contact:
neve.rowlands@md-education.com
Agenda & Faculty
October 23, 2026 | Day 1
Session I: TBD
Moderated by:
TBD
TBD
TBD
Caron Jacobson, MD
Dana-Farber Cancer Institute, Boston, MA
Jennifer Crombie, MD
Dana-Farber Cancer Institute, Boston, MA
Ryan Wilcox, MD
University of Michigan Health, Ann Arbor, MI
John Teijaro, PhD
Scripps Research Institute La Jolla, CA
Session II: Biology of Immune Deregulation in Lymphoma
Moderated by:
Michael R. Green, PhD
MD Anderson Cancer Center, Houston, TX
Samuel Yamshon, MD
NYU Langone Medical Center, New York, NY
EP
Erin Parry, MD
Dana-Farber Cancer Institute, Boston, MA
Michael Green, PhD
MD Anderson Cancer Center, Houston, TX
Mina L. Xu, MD
Yale School of Medicine, New Haven, CT
Carl June, MD
Penn Medicine, Philadelphia, PA
October 24, 2026 | Day 2
Session III: Overcoming Challenges for Cell and Immune Therapies
Moderated by:
TBD
TBD
TBD
Mark Hamilton, MD
Stanford Medicine, CA
Jean Koff, MD, MS
Emory Winship Cancer Institute, Atlanta, GA
TBD
TBD
TBD
Jeremy Abramson, MD
Massachusetts General Hospital, Boston, MA
Session IV: Targeted Strategies for Lymphoma Microenvironments
Moderated by:
TBD
TBD
TBD
Peter Martin
NYU Langone Medical Center, New York, NY
Pamela Allen, MD
Emory Winship Cancer Institute, Atlanta, GA
Todd Fehniger, MD, PhD
Washington University School of Medicine, St. Louis, MO
TBD
TBD
Industry
Session V: Future Perspectives for Microenvironment Clinical Trials
Moderated by:
TBD
TBD
TBD
RS
Roni Shouval
Memorial Sloan Kettering Cancer Center, New York, NY
Megan Lim, MD
Memorial Sloan Kettering Cancer Center, New York, NY
Stephen Ansell, MD, PhD
Mayo Clinic, Rochester, MN
Brad Kahl, MD
Washington University School of Medicine, St. Louis, MO
Neve Rowlands
Project Manager
How long has Neve Rowlands been in the business?
Neve Rowlands has been with MD Education since 2023
About Neve Rowlands
I am a dedicated project manager in the hematology industry, with a current focus on CLL and lymphoma. Specialising in logistical organisation with a sharp eye for detail, and committed to delivering high-quality, seamless events. The most rewarding part of the role is watching meetings come to life. I am passionate about connecting with both familiar and new faces, and driven by the impact of well-executed projects that support meaningful progress in the field.
